Valcrest Pharmaceuticals specializes in the development and commercialization of novel pharmaceutical products to address the special needs of patients with ultra-rare orphan diseases. The founding members of Valcrest have deep experience in the rare disease market and specific competencies in dealing with FDA regulatory requirements, clinical development, manufacturing, API sourcing, formulation development and product commercialization. Valcrest, in collaboration with a partner company, is currently advancing an innovative therapy for the treatment of Mastocytosis, a rare disorder of both children and adults caused by the presence of an excess of mast cells (mastocytes) and CD34+ mast cell precursors. People affected by Mastocytosis are susceptible to itching, hives, and anaphylactic shock, caused by the release of histamine from mast cells. Val-220, a novel oral therapy for the systemic treatment of Mastocytosis, has demonstrated an ability to stabilize mast cells and therefore control the inappropriate release of histamine. Valcrest is actively looking to add to its portfolio of new rare disease products and expects to add several additional products into development shortly.
View Top Employees from Valcrest Pharmaceuticals, LLCWebsite | http://www.valcrestpharma.com |
Revenue | $4 million |
Employees | View employees |
Founded | 2015 |
Address | 520 White Plains Rd Ste 500, Tarrytown, New York 10591, US |
Phone | (914) 500-5296 |
Technologies |
HTML,
jQuery,
Modernizr
+3 more
(view full list)
|
Industry | Manufacturing, Manufacturing General, Pharmaceuticals, Medical, Health Care, Pharmaceutical |
Competitors | Dow Development Laboratories, LLC (DDL), First Time US Generics, Regulatory Interlinx Inc, Velesco Pharmaceutical Services, Vici Health Sciences |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Valcrest Pharmaceuticals, LLC employee's phone or email?
The Valcrest Pharmaceuticals, LLC annual revenue was $4 million in 2023.
Valcrest Pharmaceuticals, LLC is based in Tarrytown, New York.
The NAICS codes for Valcrest Pharmaceuticals, LLC are [32, 3254, 325, 32541].
The SIC codes for Valcrest Pharmaceuticals, LLC are [28, 283].